These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22225576)

  • 1. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.
    Fowler CJ; Björklund E; Lichtman AH; Naidu PS; Congiu C; Onnis V
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):172-82. PubMed ID: 22225576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
    Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
    Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
    Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
    Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
    PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
    Ho WS; Randall MD
    Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of endocannabinoid system and cyclooxygenase metabolites with fatty acid amide hydrolase and cyclooxygenase enzyme activities on contractile responses in rat vas deferens tissue.
    Vural EH; Ozturk Fincan GS; Okcay Y; Askin CI; Gudul Bacanli M; Vural IM
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4123-4137. PubMed ID: 38032490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode.
    Karlsson J; Morgillo CM; Deplano A; Smaldone G; Pedone E; Luque FJ; Svensson M; Novellino E; Congiu C; Onnis V; Catalanotti B; Fowler CJ
    PLoS One; 2015; 10(11):e0142711. PubMed ID: 26565710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of diuresis and natriuresis by renomedullary infusion of a dual inhibitor of fatty acid amide hydrolase and monoacylglycerol lipase.
    Ahmad A; Daneva Z; Li G; Dempsey SK; Li N; Poklis JL; Lichtman A; Li PL; Ritter JK
    Am J Physiol Renal Physiol; 2017 Nov; 313(5):F1068-F1076. PubMed ID: 28768662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
    Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
    Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
    Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ
    J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen.
    Holt S; Nilsson J; Omeir R; Tiger G; Fowler CJ
    Br J Pharmacol; 2001 Jun; 133(4):513-20. PubMed ID: 11399668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
    Vandevoorde S; Fowler CJ
    Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
    Karbarz MJ; Luo L; Chang L; Tham CS; Palmer JA; Wilson SJ; Wennerholm ML; Brown SM; Scott BP; Apodaca RL; Keith JM; Wu J; Breitenbucher JG; Chaplan SR; Webb M
    Anesth Analg; 2009 Jan; 108(1):316-29. PubMed ID: 19095868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen.
    Fowler CJ; Janson U; Johnson RM; Wahlström G; Stenström A; Norström K; Tiger G
    Arch Biochem Biophys; 1999 Feb; 362(2):191-6. PubMed ID: 9989926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of endocannabinoid metabolism by the metabolites of ibuprofen and flurbiprofen.
    Karlsson J; Fowler CJ
    PLoS One; 2014; 9(7):e103589. PubMed ID: 25061885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and
    Deplano A; Karlsson J; Moraca F; Svensson M; Cristiano C; Morgillo CM; Fowler CJ; Russo R; Catalanotti B; Onnis V
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):940-953. PubMed ID: 33896320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
    Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
    Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase.
    Hillard CJ; Shi L; Tuniki VR; Falck JR; Campbell WB
    J Mol Neurosci; 2007 Sep; 33(1):18-24. PubMed ID: 17901541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
    Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.